Abstract Objective To investigate the clinical features of invasive candidiasis in children and the risk factors for Candida bloodstream infection. Methods A retrospective study was performed on 134 children with invasive candidiasis and hospitalized in 5 tertiary hospitals in Urumqi, China, between January 2010 and December 2015. The Candida species distribution was investigated. The clinical data were compared between the patients with and without Candida bloodstream infection. The risk factors for Candida bloodstream infection were investigated using multivariate logistic regression analysis. Results A total of 134 Candida strains were isolated from 134 children with invasive candidiasis, and non-albicans Candida (NAC) accounted for 53.0%. The incidence of invasive candidiasis in the PICU and other pediatric wards were 41.8% and 48.5% respectively. Sixty-eight patients (50.7%) had Candida bloodstream infection, and 45 patients (33.6%) had Candida urinary tract infection. There were significant differences in age, rate of use of broad-spectrum antibiotics, and incidence rates of chronic renal insufficiency, heart failure, urinary catheterization, and NAC infection between the patients with and without Candida bloodstream infection (P < 0.05). The multivariate logistic regression analysis showed that younger age (1-24 months) (OR=6.027) and NAC infection (OR=1.020) were the independent risk factors for Candida bloodstream infection. Conclusions The incidence of invasive candidiasis is similar between the PICU and other pediatric wards. NAC is the most common species of invasive candidiasis. Candida bloodstream infection is the most common invasive infection. Younger age (1-24 months) and NAC infection are the risk factors for Candida bloodstream infection.
AI Bi Bai·,AI Er Ken,MA Zhi-Hua et al. Clinical features of invasive candidiasis and risk factors for Candida bloodstream infection in children: a multicenter study in Urumqi, China[J]. CJCP, 2017, 19(4): 414-418.
AI Bi Bai·,AI Er Ken,MA Zhi-Hua et al. Clinical features of invasive candidiasis and risk factors for Candida bloodstream infection in children: a multicenter study in Urumqi, China[J]. CJCP, 2017, 19(4): 414-418.
Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures[J]. Clin Microbiol Infect, 2012, 18(Suppl 7):9-18.
Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 48(5):503-535.
[4]
Celebi S, Hacimustafaoglu M, Ozdemir O, et al. Nosocomial candidaemia in children:results of a 9-year study[J]. Mycoses, 2008, 51(3):248-257.
[5]
Pemán J, Cantón E, Quindós G, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey[J]. Antimicrob Chemother, 2012, 67(5):1181-1187.
[6]
Hegazi M, Abdelkader A, Zaki M, et al. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt[J]. J Infect Dev Ctries, 2014, 8(5):624-634.
[7]
Wisplinghoff H, Ebbers J, Geurtz L, et al. Nosocomial bloodstream infections due to Candida spp. in the USA:species distribution, clinical features and antifungal susceptibilities[J]. Int J Antimicrob Agents, 2014, 43(3):78-81.
[8]
Oliveira VK, Ruiz Lda S, Oliveira NA, et al. Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil:study in the period 2007-2010[J]. Rev Inst Med Trop Sao Paulo, 2014, 56(4):301-305.
[9]
Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population[J]. Pediatr Infect Dis, 2011, 30(8):664-668.
[10]
Kuzucu C, Durmaz R, Otlu B, et al. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey[J]. New Microbiol, 2008, 31(3):401-408.
Chen CY, Sheng WH, Huang SY, et al. Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12[J]. J Antimicrob Chemother, 2015, 70(5):1531-1538.
[14]
Erdem F, Tuncer Ertem G, Oral B, et al. Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species[J]. Mikrobiyol Bul, 2012, 46(4):637-648.
